9873 related articles for article (PubMed ID: 1340180)
1. Tumorigenicity and metastatic ability of MmB16 mouse melanoma cell line and its two Aleuria aurantia agglutinin resistant variants.
Duś D; Matuszyk J; Kuśnierczyk H; Strzadała L; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1992; 40(5-6):263-9. PubMed ID: 1340180
[TBL] [Abstract][Full Text] [Related]
2. Lectin-resistant variants of mouse Lewis lung carcinoma cells. I. Selection and in vivo properties.
Dus D; Debray H; Strzadala L; Rak J; Kusnierczyk H; Montreuil J; Radzikowski C
Clin Exp Metastasis; 1990; 8(3):277-86. PubMed ID: 2328548
[TBL] [Abstract][Full Text] [Related]
3. Tumor progression in vivo: increased soybean agglutinin lectin binding, N-acetylgalactosamine-specific lectin expression, and liver metastasis potential.
Reese MR; Chow DA
Cancer Res; 1992 Oct; 52(19):5235-43. PubMed ID: 1394127
[TBL] [Abstract][Full Text] [Related]
4. Generation of phenotypic diversity in the B16 mouse melanoma relative to spontaneous metastasis.
Stackpole CW
Cancer Res; 1983 Jul; 43(7):3057-65. PubMed ID: 6850615
[TBL] [Abstract][Full Text] [Related]
5. Metastatic variants of the B16 melanoma: metastasis is related to environmental conditions. Phenotypic changes in vitro and metastatic colonization potential in nude mice.
Aubert C
Melanoma Res; 1995 Jun; 5(3):139-46. PubMed ID: 7640514
[TBL] [Abstract][Full Text] [Related]
6. Enforced expression of MCAM/MUC18 increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model.
Wu GJ; Fu P; Wang SW; Wu MW
Mol Cancer Res; 2008 Nov; 6(11):1666-77. PubMed ID: 19010815
[TBL] [Abstract][Full Text] [Related]
7. Selection of metastatic variants from heterogeneous tumor cell lines using the chicken chorioallantoic membrane and nude mouse.
Dexter DL; Lee ES; DeFusco DJ; Libbey NP; Spremulli EN; Calabresi P
Cancer Res; 1983 Apr; 43(4):1733-40. PubMed ID: 6831418
[TBL] [Abstract][Full Text] [Related]
8. Single-step selection of unique human melanoma variants displaying unusually aggressive metastatic behavior in nude athymic mice.
Kerbel RS; Man MS
Invasion Metastasis; 1984; 4 Suppl 1():31-43. PubMed ID: 6533097
[TBL] [Abstract][Full Text] [Related]
9. [Immunogenicity of 2 murine B16 melanoma variants with high metastatic potential].
Hosni M; Santini R; Deschaux P; Pacheco H
C R Seances Soc Biol Fil; 1990; 184(1):47-54. PubMed ID: 2150781
[TBL] [Abstract][Full Text] [Related]
10. Immunologic studies of membrane mutants of a highly metastatic murine tumor.
Kerbel RS
Am J Pathol; 1979 Dec; 97(3):609-22. PubMed ID: 507193
[TBL] [Abstract][Full Text] [Related]
11. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
12. Tabulation of results on the heterogeneity of cellular characteristics among cells from B16 mouse melanoma cell lines with different colonization potentials. A summary of sixty reports.
Maslow DE
Invasion Metastasis; 1989; 9(3):182-91. PubMed ID: 2656569
[TBL] [Abstract][Full Text] [Related]
13. Characterization in vitro and in vivo of progressively adriamycin-resistant B16-BL6 mouse melanoma cells.
Ganapathi R; Grabowski D; Schmidt H; Bell D; Melia M
Cancer Res; 1987 Jul; 47(13):3464-8. PubMed ID: 2884031
[TBL] [Abstract][Full Text] [Related]
14. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response.
Wack C; Kirst A; Becker JC; Lutz WK; Bröcker EB; Fischer WH
Cancer Immunol Immunother; 2002 Oct; 51(8):431-9. PubMed ID: 12202904
[TBL] [Abstract][Full Text] [Related]
15. Partial reversion of the metastatic phenotype in a wheat germ agglutinin-resistant mutant of the murine tumor cell line MDAY-D2 selected with Bandeiraea simplicifolia seed lectin.
Dennis JW
J Natl Cancer Inst; 1985 May; 74(5):1111-20. PubMed ID: 3858579
[TBL] [Abstract][Full Text] [Related]
16. Poorly metastatic tumor cell variants as primary targets of syngeneic antibody responses against murine melanoma.
Parratto NP; Odebralski JM; Kimura AK
Cancer Res; 1989 Jul; 49(14):3722-8. PubMed ID: 2736512
[TBL] [Abstract][Full Text] [Related]
17. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
[TBL] [Abstract][Full Text] [Related]
18. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.
Murakami T; Maki W; Cardones AR; Fang H; Tun Kyi A; Nestle FO; Hwang ST
Cancer Res; 2002 Dec; 62(24):7328-34. PubMed ID: 12499276
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.
Poste G; Doll J; Brown AE; Tzeng J; Zeidman I
Cancer Res; 1982 Jul; 42(7):2770-8. PubMed ID: 7083167
[TBL] [Abstract][Full Text] [Related]
20. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential.
Turpeenniemi-Hujanen T; Thorgeirsson UP; Hart IR; Grant SS; Liotta LA
J Natl Cancer Inst; 1985 Jul; 75(1):99-103. PubMed ID: 2989606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
